In addition, cisplatin experiments with cell counting kit‐8, colony formation, and a xenograft mice model of NPC demonstrated that NEK2 contributed to proliferation and cisplatin resistance in vitro and in vivo. The gene discussed is NEK2; the disease is nasopharyngeal carcinoma.